Surveillance To Track Progress Toward Poliomyelitis Eradication — Worldwide, 2021–2022
暂无分享,去创建一个
O. Diop | J. Jorba | Tasha Stehling-Ariza | G. Tallis | L. Sangal | Sudhir Joshi | S. Sharif | Stephanie D. Kovacs | H. Asghar | A. Wilkinson | A. Kfutwah | A. Wahdan | Varja Grabovac | T. Johnson | Tigran Avagnan
[1] F. Mahoney,et al. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022 , 2023, MMWR. Morbidity and mortality weekly report.
[2] I. Spicknall,et al. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox — United States, May 22, 2022–January 31, 2023 , 2023, MMWR. Morbidity and mortality weekly report.
[3] R. Link-Gelles,et al. Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023 , 2023, MMWR. Morbidity and mortality weekly report.
[4] Stuart H. Cohen,et al. Mpox Infection in Children—Infection Control Implications for Household Contacts , 2023, Open forum infectious diseases.
[5] T. Shimabukuro,et al. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 , 2023, MMWR. Morbidity and mortality weekly report.
[6] M. Reynolds,et al. Mpox in Children and Adolescents: Epidemiology, Clinical Features, Diagnosis, and Management. , 2022, Pediatrics.
[7] William T. Robinson,et al. The Effect of Navigation on Linkage to a PrEP Provider Among PrEP-Eligible Men who have Sex with Men in a U.S. Demonstration Project , 2022, AIDS and Behavior.
[8] Jonathan Bryant-Genevier,et al. Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response — United States, May 17–October 6, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[9] Sunanda R. McGarvey,et al. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[10] T. Shimabukuro,et al. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[11] S. D. de Paula,et al. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development , 2022, Viruses.
[12] D. Gubler,et al. The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines , 2022, PLoS neglected tropical diseases.
[13] O. Diop,et al. Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2019–2020 , 2021, MMWR. Morbidity and mortality weekly report.
[14] E. Holmes,et al. Epidemiologic History and Genetic Diversity Origins of Chikungunya and Dengue Viruses, Paraguay , 2021, Emerging infectious diseases.
[15] O. Diop,et al. Impact of COVID-19 Pandemic on Global Poliovirus Surveillance , 2021, MMWR. Morbidity and mortality weekly report.
[16] T. Monath. The Arboviruses: Epidemiology and Ecology , 2019 .
[17] J. Grey,et al. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. , 2018, Annals of epidemiology.
[18] Sarah Paige,et al. Multisectoral prioritization of zoonotic diseases in Uganda, 2017: A One Health perspective , 2018, PloS one.
[19] M. Pallansch,et al. The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks , 2017, The Journal of infectious diseases.
[20] F. Destefano,et al. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). , 2015, Vaccine.
[21] Amartya Sen,et al. Public action and the quality of life in developing countries. , 2009, Oxford bulletin of economics and statistics.
[22] F. Arenzana‐Seisdedos,et al. Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion , 2008, PLoS medicine.
[23] T. Ksiazek,et al. Highly Sensitive and Broadly Reactive Quantitative Reverse Transcription-PCR Assay for High-Throughput Detection of Rift Valley Fever Virus , 2007, Journal of Clinical Microbiology.
[24] Jennifer Prah Ruger,et al. Ethics and governance of global health inequalities , 2006, Journal of Epidemiology and Community Health.
[25] M. Bouloy,et al. Rift Valley fever virus. , 2005, Current molecular medicine.
[26] S. Harper,et al. [Implicit value judgments in the measurement of health inequalities]. , 2014, Revista panamericana de salud publica = Pan American journal of public health.
[27] David Heymann. Global polio eradication initiative. , 2006, Bulletin of the World Health Organization.